Dr Stephen Chambers
Stephen Chambers is the CEO of SynbiCITE and has a wealth of experience in life science based start-up companies.
Having completed his PhD at the University of Warwick, Steve joined the then start-up Vertex Pharmaceuticals as a founding scientist. This took him to the US where he was part of one of the most successful US pharma companies in recent history. Steve later became a co-founder of Abpro, a Massachusetts based biotechnology company specialising in rapid antibody production.
After 24 years in the US, Steve returned to the UK to head up SynbiCITE. He recognised the growing momentum of synthetic biology in the UK, particularly among companies who were looking to exploit and commercialise this technology. As CEO of SynbiCITE Steve is able to support start-ups and help to build a synthetic biology-based manufacturing industry in the UK.